Anavex Life Sciences Corp (AVXL)

[Amatuer17]

Watched ‘Needham Virtual Neuroscience Forum’ and here is my take

1. While M was not the smooth-sophisticated CEO that we see in many other biotechs, he was much confident than before and gave much cleaner answers.

2. He fumbled on RSBQ and similar drilling questions on Rett but not main worry.

3. He gave more concrete timelines on some key items

a. planned to start 2 new trials in H2 related to PDD. (Not SP impact in my view)

b. Rett related meeting, FDA feedback and then Rett Pediatric results - he seemed confident to get results by year end (not as confident as AD timing)

c. AD results - he was quite confident of the results to come in H2 (before year end) as the 48 weeks end by mid 2023.

4. There were many other items but not as impactful in my mind.

For me - AD results will be the main event - if Rett pediatric results also come - icing.

5. The o/s are 76 million - at $13 - the market cap is $1 Billion

If AD results are good - we can cross $3 B market cap very easily.

Despite all my skepticism about M capability, I will be gambling my stocks till AD results. If Rett results come before that and impact SP, I will still wait for AD results.